ERIC VIEIRA,WOLFGANG GUBA,GEORG JAESCHKE,ANTONIO RICCI,DANIEL RUEHER,BARBARA BIEMANS,JEAN-MARC PLANCHER,FIONN O,HARA
申请号:
PT15706788
公开号:
PT3110802T
申请日:
2015.02.24
申请国别(地区):
PT
年份:
2018
代理人:
摘要:
The present invention relates to compounds that may be used in the treatment or prevention of disorders relating to allosteric modulation of the mGluR4 receptor. Such compounds may be used for the treatment of Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2.